Literature DB >> 9371501

Apc gene mutation is associated with a dominant-negative effect upon intestinal cell migration.

N N Mahmoud1, S K Boolbol, R T Bilinski, C Martucci, A Chadburn, M M Bertagnolli.   

Abstract

Apc-associated intestinal tumor formation appears to require functional loss of both Apc alleles. Apc has, therefore, been classified as a tumor suppressor gene. Loss of APC protein function results in increased intracellular beta-catenin, a molecule important to both cell-cell adhesion and regulation of cellular growth. In mice bearing a germ-line Apc mutation, we found that enterocyte beta-catenin expression was also increased in histologically normal intestinal mucosa. Enterocyte crypt-villus migration was decreased by 25%, and treatment of Min/+ animals with sulindac sulfide normalized both beta-catenin expression and enterocyte migration. Our data suggest that alterations in enterocyte migration occur in cells bearing a single mutant Apc allele, and that sulindac sulfide may normalize enterocyte growth in these cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371501

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  45 in total

Review 1.  COX-2 and cancer: a new approach to an old problem.

Authors:  Y S Bakhle
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

2.  Clonal structure of carcinogen-induced intestinal tumors in mice.

Authors:  Andrew T Thliveris; Linda Clipson; Alanna White; Jesse Waggoner; Lauren Plesh; Bridget L Skinner; Christopher D Zahm; Ruth Sullivan; William F Dove; Michael A Newton; Richard B Halberg
Journal:  Cancer Prev Res (Phila)       Date:  2011-06

Review 3.  Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting.

Authors:  William Hankey; Wendy L Frankel; Joanna Groden
Journal:  Cancer Metastasis Rev       Date:  2018-03       Impact factor: 9.264

Review 4.  Multiple Roles of APC and its Therapeutic Implications in Colorectal Cancer.

Authors:  Lu Zhang; Jerry W Shay
Journal:  J Natl Cancer Inst       Date:  2017-08-01       Impact factor: 13.506

5.  Apc(MIN) modulation of vitamin D secosteroid growth control.

Authors:  Haibo Xu; Gary H Posner; Michael Stevenson; Frederick C Campbell
Journal:  Carcinogenesis       Date:  2010-05-20       Impact factor: 4.944

Review 6.  Corruption of homeostatic mechanisms in the guanylyl cyclase C signaling pathway underlying colorectal tumorigenesis.

Authors:  Peng Li; Scott A Waldman
Journal:  Cancer Biol Ther       Date:  2010-08-11       Impact factor: 4.742

7.  A simple algebraic cancer equation: calculating how cancers may arise with normal mutation rates.

Authors:  Peter Calabrese; Darryl Shibata
Journal:  BMC Cancer       Date:  2010-01-05       Impact factor: 4.430

8.  Novel association of APC with intermediate filaments identified using a new versatile APC antibody.

Authors:  Yang Wang; Yoshiaki Azuma; David B Friedman; Robert J Coffey; Kristi L Neufeld
Journal:  BMC Cell Biol       Date:  2009-10-21       Impact factor: 4.241

9.  Deficiency of the LIM-only protein FHL2 reduces intestinal tumorigenesis in Apc mutant mice.

Authors:  Charlotte Labalette; Yann Nouët; Florence Levillayer; Sabine Colnot; Ju Chen; Valere Claude; Michel Huerre; Christine Perret; Marie-Annick Buendia; Yu Wei
Journal:  PLoS One       Date:  2010-04-28       Impact factor: 3.240

Review 10.  APC and its modifiers in colon cancer.

Authors:  Lawrence N Kwong; William F Dove
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.